InsiderTrades.com logo
Is Starlink Set For The Largest IPO In History?
From Paradigm Press   |   Ad
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000!
Click here now for the urgent details.

RAPP Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $1,079,664.64
Insider Selling (Last 12 Months): $0.00

Rapport Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Rapport Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Rapport Therapeutics Share Price & Price History

Current Price: $21.23
Price Change: ▲ Price Increase of +0.98 (4.84%)
As of 09/20/2024 01:00 AM ET

This chart shows the closing price history over time for RAPP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown”
From Paradigm Press   |   Ad
Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.
Click here to see it because it’s a SHOCKER…

Rapport Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/1/2024James HealyDirectorBuy44,032$24.52$1,079,664.6440,851View SEC Filing Icon  
See Full Table
"Doomsday indicator” flashing for the first time since the Great Depression...
From Behind the Markets   |   Ad
It's been a bloodbath in the markets. The seven most valuable US tech companies lost a combined $1 trillion - in a single day. And things could get a lot worse...
Click here to discover how Wall Street insiders are quietly preparing for a market crash >>>

SEC Filings (Institutional Ownership Changes) for Rapport Therapeutics (NASDAQ:RAPP)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RAPP by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Rapport Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/27/2024Logos Global Management LP208,910$4.86M0.4%N/A0.591%Search for SEC Filing on Google Icon
8/16/2024Perceptive Advisors LLC748,183$17.40M0.4%N/A2.045%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company 75,516$1.76M0.0%N/A0.206%Search for SEC Filing on Google Icon
8/15/2024Millennium Management LLC116,782$2.72M0.0%N/A0.319%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC16,345$0.38M0.0%N/A0.045%Search for SEC Filing on Google Icon
8/14/2024Sandia Investment Management LP5,000$0.12M0.2%N/A0.014%Search for SEC Filing on Google Icon
8/14/2024ARCH Venture Management LLC3,728,738$86.73M31.6%N/A10.193%Search for SEC Filing on Google Icon
8/14/2024Davidson Kempner Capital Management LP10,000$0.23M0.0%N/A0.027%Search for SEC Filing on Google Icon
8/10/2024Sofinnova Investments Inc.1,951,562$45.39M2.4%N/A5.516%Search for SEC Filing on Google Icon
8/9/2024Johnson & Johnson2,498,051$58.11M14.5%N/A7.061%Search for SEC Filing on Google Icon
8/3/2024TD Asset Management Inc101,522$2.36M0.0%N/A0.287%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Rapport Therapeutics logo
Rapport Therapeutics Inc. is a clinical-stage biotechnology company. It focused on discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. Rapport Therapeutics Inc. is based in BOSTON.
Read More on Rapport Therapeutics

Today's Range

Now: $21.23
Low: $19.12
High: $21.66

50 Day Range

MA: $20.99
Low: $18.27
High: $27.57

52 Week Range

Now: $21.23
Low: $16.55
High: $28.08

Volume

2,193,000 shs

Average Volume

186,104 shs

Market Capitalization

$776.59 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Rapport Therapeutics?

Rapport Therapeutics' top insider shareholders include:
  1. James Healy (Director)
Learn More about top insider investors at Rapport Therapeutics.

Who are the major institutional investors of Rapport Therapeutics?

Rapport Therapeutics' top institutional shareholders include:
  1. ARCH Venture Management LLC — 10.19%
  2. Johnson & Johnson — 7.06%
  3. Sofinnova Investments Inc. — 5.52%
  4. Perceptive Advisors LLC — 2.05%
  5. Logos Global Management LP — 0.59%
  6. Millennium Management LLC — 0.32%
Learn More about top institutional investors of Rapport Therapeutics stock.

Which major investors are buying Rapport Therapeutics stock?

During the previous quarter, RAPP stock was acquired by institutional investors including:
  1. ARCH Venture Management LLC
  2. Johnson & Johnson
  3. Sofinnova Investments Inc.
  4. Perceptive Advisors LLC
  5. Logos Global Management LP
  6. Millennium Management LLC
  7. TD Asset Management Inc
  8. The Manufacturers Life Insurance Company
Is Starlink Set For The Largest IPO In History?
From Paradigm Press   |   Ad
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000!
Click here now for the urgent details.